Atorvastatin prevents Plasmodium falciparum cytoadherence and endothelial damage. - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Malaria Journal Year : 2011

Atorvastatin prevents Plasmodium falciparum cytoadherence and endothelial damage.


BACKGROUND: The adhesion of Plasmodium falciparum parasitized red blood cell (PRBC) to human endothelial cells (EC) induces inflammatory processes, coagulation cascades, oxidative stress and apoptosis. These pathological processes are suspected to be responsible for the blood-brain-barrier and other organs' endothelial dysfunctions observed in fatal cases of malaria. Atorvastatin, a drug that belongs to the lowering cholesterol molecule family of statins, has been shown to ameliorate endothelial functions and is widely used in patients with cardiovascular disorders. METHODS: The effect of this compound on PRBC induced endothelial impairments was assessed using endothelial co-culture models. RESULTS: Atorvastatin pre-treatment of EC was found to reduce the expression of adhesion molecules and P. falciparum cytoadherence, to protect cells against PRBC-induced apoptosis and to enhance endothelial monolayer integrity during co-incubation with parasites. CONCLUSIONS: These results might suggest a potential interest use of atorvastatin as a protective treatment to interfere with the pathophysiological cascades leading to severe malaria.
Fichier principal
Vignette du fichier
1475-2875-10-52.pdf (402.9 Ko) Télécharger le fichier
1475-2875-10-52.xml (66.09 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Format : Other

Dates and versions

inserm-00663669 , version 1 (27-01-2012)



Zacharie Taoufiq, Paco Pino, Nadine N'Dilimabaka, Issam Arrouss, Serge Assi, et al.. Atorvastatin prevents Plasmodium falciparum cytoadherence and endothelial damage.. Malaria Journal, 2011, 10 (1), pp.52. ⟨10.1186/1475-2875-10-52⟩. ⟨inserm-00663669⟩
198 View
435 Download



Gmail Facebook Twitter LinkedIn More